TheraSight® Expression Profiler
TheraSight® Expression Profiler measures the activity of all human genes (transcriptome). Based on numerous published gene expression signatures, TheraSight® Expression Profiler provides the treating oncologist with a wealth of valuable information for personalized therapeutic decisions.
THERASIGHT® Ultraview Profiler
THERASIGHT® Ultraview Profiler, indispensable for an individualized comprehensive precision oncology treatment, is a unique state-of-the-art assay amalgamating the patient’s transcriptome data (TheraSight® Expression Profiler) and therapeutically important mutation data (TheraSight® Mutation Profiler) from Gen Mutation Panels.
Circulating Tumor DNA
Circulating tumor DNA (cfDNA) represents an accurate reflection of a tumor’s mutation pattern in the blood plasma. It is mostly used for real-time response monitoring to targeted drug treatment and as a surrogate analysis of a tumor’s mutational status in cases where no tumor tissue is accessible.